Back to top
more

McKesson (MCK)

(Real Time Quote from BATS)

$563.92 USD

563.92
576,442

-0.08 (-0.01%)

Updated May 21, 2024 09:38 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 34% (164 out of 248)

Industry: Medical - Dental Supplies

Better trading starts here.

Zacks News

Are Investors Undervaluing McKesson (MCK) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

McKesson (MCK) Hits 52-Week High: What's Driving the Stock?

Investors are optimistic about McKesson's (MCK) strength in its Biologics business.

Is First Trust Consumer Staples AlphaDEX ETF (FXG) a Strong ETF Right Now?

Smart Beta ETF report for FXG

Here's Why McKesson (MCK) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Is Cardinal Health (CAH) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Shaun Pruitt headshot

3 Attractive Medical Stocks to Buy After Earnings

Following their favorable quarterly results this week here are three intriguing healthcare stocks that investors will want to consider.

Zimmer Biomet (ZBH) Q4 Earnings Top Estimates, Margins Grow

Each of Zimmer Biomet's (ZBH) geographic segments records strong year-over-year sales growth on a reported basis, as well as at CER in the fourth quarter.

McKesson (MCK) Beats on Q3 Earnings, Raises FY24 EPS View

McKesson's (MCK) third-quarter fiscal 2024 results benefit from growth in the United States. Divestment hurts the International segment.

Here's What Key Metrics Tell Us About McKesson (MCK) Q3 Earnings

The headline numbers for McKesson (MCK) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

CVS Health (CVS) Q4 Earnings Top Estimates, 2024 EPS View Down

Robust sales growth across all three operating segments contributes to CVS Health's (CVS) Q4 revenues.

Edwards Lifesciences (EW) Q4 Earnings Meet, Margins Dip

Edwards Lifesciences' (EW) Q4 revenues register year-over-year growth on its strong differentiated portfolio of advanced therapies.

GE HealthCare (GEHC) Q4 Earnings Beat, Volume & Price Improve

GE HealthCare's (GEHC) fourth-quarter results benefit from continued demand for imaging, patient care and pharmaceutical diagnostic solutions. Sales gain from improved pricing.

McKesson (MCK) to Report Q3 Earnings: What's in the Cards?

McKesson's (MCK) third-quarter fiscal 2024 results are likely to reflect the solid display by the U.S. Pharmaceutical and Specialty Solutions segment.

Sweta Killa headshot

5 Dividend Growth Stocks to Buy for a Safe Portfolio

Installed Building Products (IBP), PACCAR. (PCAR), McKesson (MCK), Republic Services (RSG) and PulteGroup (PHM) seem solid choices for a safe portfolio amid the current market volatility.

IDEXX (IDXX) Q4 Earnings Surpass Estimates, Margins Fall

Across testing modalities, IDEXX (IDXX) achieves strong global growth in the fourth quarter.

McKesson Corporation (MCK) Hits Fresh High: Is There Still Room to Run?

McKesson (MCK) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Here's How Much You'd Have If You Invested $1000 in McKesson a Decade Ago

Holding on to popular or trending stocks for the long-term can make your portfolio a winner.

Is Elevance Health, Inc. (ELV) Outperforming Other Medical Stocks This Year?

Here is how Elevance Health (ELV) and McKesson (MCK) have performed compared to their sector so far this year.

Exploring Analyst Estimates for McKesson (MCK) Q3 Earnings, Beyond Revenue and EPS

Evaluate the expected performance of McKesson (MCK) for the quarter ended December 2023, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Quest Diagnostics (DGX) Q4 Revenues Top, Gross Margin Down

Quest Diagnostics (DGX) delivers better-than-expected earnings and revenues in the fourth quarter of 2023.

Cardinal Health, Inc. (CAH) Hits Fresh High: Is There Still Room to Run?

Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

McKesson (MCK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

McKesson (MCK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here's Why McKesson (MCK) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.